Morphological Patterns of Ovarian Neoplasms in Different Age Groups - A Center based study

Similar documents
Nature and Science 2015;13(4)

Ovarian tumors Ancillary methods

Male Breast Cancer. Abstract

New Hampshire Childhood Cancer

A RETROSPECTIVE STUDY OF OVARIAN TUMOURS AND TUMOUR-LIKE LESIONS

Gynecology Abnormal Physiology of the ovaries. Simple Cystic Masses

Ovarian Cysts Made Simple Michael East. Oxford Clinic

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

ProSono Copyright Ovarian Pathology

POSTMENOPAUSAL ASSESS AND WHAT TO DO

Try out the online ROMA calculator available on the Elecsys HE4 page at cobas.com

OVARIAN CYSTS. Types of Ovarian Cysts There are many types of ovarian cysts and these can be categorized into functional and nonfunctional

Ovarian Cancer: A Case Report

Benign Ovarian Masses

PROTOCOL OF THE RITA DATA QUALITY STUDY

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Nicole Kounalakis, MD

Frequently Asked Questions About Ovarian Cancer

The Adnexal Mass and Early Ovarian Cancer

The Diagnosis of Cancer in the Pathology Laboratory

R-16: Chronic nonspecific cervisit

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Something Old, Something New.

La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia?

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

Ovarian cysts Diagnosis and Management

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum

Introduction Ovarian cysts are a very common female condition. An ovarian cyst is a fluid-filled sac on an ovary in the female reproductive system.

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Ovarian mucinous lesions. Ovarian mucinous lesions: Common diagnostic dilemmas. Ovarian mucinous lesions: problematic issues

Ovarian masses - CT imaging

Fertility Preservation in Women with Cancer. Objectives. Patient #1 10/24/2011. The audience will understand: How cancer therapy affects fertility.

Progress and Prospects in Ovarian Cancer Screening and Prevention

Giant Cysts of Ovary, A Benign Neoplastic Disease Mimicking Ascites

Update on Mesothelioma

Report series: General cancer information

THYROID CANCER. I. Introduction

Cancer in Ireland 2013: Annual report of the National Cancer Registry

Carcinosarcoma of the Ovary

Immunohistochemical differentiation of metastatic tumours

The Radiologic Evaluation of the Ovary

Chapter 14 Cancer of the Cervix Uteri

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for

Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.

Common Cancers & Hereditary Syndromes

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics

Male. Female. Death rates from lung cancer in USA

Ovarian Cancer. What is cancer?

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

Ovarian Cancer. in Georgia, Georgia Department of Human Resources Division of Public Health

OVARIAN CYSTS, MASSES and other pains OBJECTIVES FETAL AND NEONATAL OVARIAN CYSTS 11/26/2012. Anne Marie Priebe, DO

Rare Thoracic Tumours

The Ontario Cancer Registry moves to the 21 st Century

Asbestos Exposure and Ovarian Fiber Burden

CLINICAL MANAGEMENT OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

TIME TREND IN TUMOR DISEASE INCIDENCE IN CHILDREN AND ADOLES- CENTS IN THE CZECH REPUBLIC

Medullary Renal Cell Carcinoma Case Report

Cervical Cancer The Importance of Cervical Screening and Vaccination

The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006

WOMENCARE A Healthy Woman is a Powerful Woman (407) Ovarian Cysts

PROFILE OF THE SINGAPORE CHINESE DIALECT GROUPS

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

DISCLOSURE OBJECTIVES IN THE INEREST OF TIME LAPAROSCOPY AND AN APPROACH TO THE ADNEXAL MASS

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Risk of Malignancy in Unilocular Ovarian Cystic Tumors Less Than 10 Centimeters in Diameter

Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum.

Ovarian cancer. A guide for journalists on ovarian cancer and its treatment

Renal Pathology Update. Sundus Hussein MD, FRCPC

In The Abstract A quarterly newsletter from the

Predictive Value of Symptoms for Early Detection of Ovarian Cancer

THE DIAGNOSTIC VALIDITY OF PRE-OPERATIVE SERUM CA125 LEVEL IN WOMEN WITH OVARIAN MASSES

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

Understanding Your Risk of Ovarian Cancer

Prostate cancer statistics

Histopathology of Major Salivary Gland Neoplasms

Effusions: Mesothelioma and Metastatic Cancers

Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore National Registry of Diseases Office (NRDO)

Polyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1

Pathology of lung cancer

Intraobserver and Interobserver Reproducibility of WHO and Gleason Histologic Grading Systems in Prostatic Adenocarcinomas

PRINIPLES OF RADIATION THERAPY Adarsh Kumar. The basis of radiation therapy revolve around the principle that ionizing radiations kill cells

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

Frozen Section Diagnosis

Variations in Appearance of Endometriomas

Understanding ductal carcinoma in situ (DCIS) and deciding about treatment

Safe and Effective Surgery for Endometriosis Including Detection and Intervention for Ovarian Cancer

OBJECTIVES By the end of this segment, the community participant will be able to:

Primary -Benign - Malignant Secondary

Independent Validation of the Prognostic Gene Expression Ratio Test in Formalin Fixed, Paraffin Embedded (FFPE) Mesothelioma Tumor Tissue Specimens

Morphological Variants of Papillary Carcinoma of Thyroid

Explanation of your PAP smear

Parametric mapping of contrasted ovarian transvaginal sonography.

Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds

Gynecologic Cancer in Women with Lynch Syndrome

IV. DEMOGRAPHIC PROFILE OF THE OLDER POPULATION

Fact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)?

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14

Transcription:

ORIGINAL ARTICLE Morphological Patterns of Ovarian Neoplasms in Different Age Groups - A Center based study RAFIA BILQUEES SIDDIQUI 1, BHAWANI SHANKAR 2, M. IRFAN KHAN 3 ABSTRACT Aim: To study the morphological patterns of ovarian tumors received in the department of Pathology, BMSI, JPMC over a period of five years. Background: The most common type of lesions encountered in the ovary include functional or benign cysts and ovarian tumors. Ovarian tumor accounts for 6%of all cancers in the female population. Mature cystic teratoma is the most common germ cell tumor of ovary occurring at any age with a peak incidence in the first two decades of life. Malignant transformation of a mature cystic teratoma is an uncommon complication occurring in approximately 1-3% of mature cystic teratomas. Methods: A retrospective study was conducted at the department of Pathology, BMSI,JPMC and all ovarian specimens received over a period of five years i.e., January 2008 to 31 December 2009 were received. All specimens were formalin fixed, routinely processed for paraffin embedding, sectioned and finally stained with haematoxylin and eosin using standard procedures. Results: During the study period, a total of 1075 ovarian specimens were received out of which the ovaries of 508 cases were unremarkable. Out of remaining 567 cases 209(52.7%) were non neoplastic and 237(22%) were neoplastic lesions. Out of the neoplastic lesions, 185(17.2%) cases were benign tumors. The malignant lesions comprised of 2(.18%) immature cystic teratomas, 27(2.5%) mucinous cystadenocarcinomas, 23(2.1%) serous cystadenocarcinomas and 4(0.37%) were granulosa cell tumors. There was a rare case of mucinous cystadenocarcinoma arising from mature cystic teratoma in a 31 year old female. Conclusion: We conclude that the commonest malignant tumor was mucinous cystadenocarcinoma followed by serous cystadenocarcinomas. We also suggest that all teratomas showing an overwhelming mucinous component should be thoroughly sampled and reviewed in order not to miss the diagnosis of malignancy and to avoid a misdiagnosis of mature teratomas. Keywords: ovarian tumors, mucinous cystadenocarcinoma, mature cystic teratoma. INTRODUCTION Ovarian cancer often called silent killer is the sixth most common cancer in the female population and subsequently a leading cause of death. It is one of the most intriguing tumors with diverse histological patterns and their ultimate behavior. Ovarian malignancies can be harbored in any age group with ovarian germ cell tumors seen in the younger age group and the malignant variety seen in the more elderly. Of all the malignancies encountered in the female population 15 20% are of ovarian nature 1. Structural changes in ovary are responsible for formation of benign and malignant tumors which can arise from the epithelial wall of ovary, germinal epithelium or connective tissue of ovary. Cancer of the ovary is the most frequent cause of death from ---------------------------------------------------------------------- 1 Assistant Professor, Department of Pathology, Karachi Medical & Dental College, Karachi 2 Assistant Professor of Pathology, Bhatti Medical & Dental College, Mirpurkhas 3 Assistant Professor, Department of Pathology, Karachi Medical & Dental College, Karachi Correspondence to Dr. Rafia Bilquees Siddiqui Email: rafiasiddiqui_70@yahoo.com gynecologic malignancies and the fourth most common cause of death from cancer in woman in Europe and United States 2 simulating the results from Pakistan the fourth most common malignancies encountered is of ovarian nature 3. The definite categorization of ovarian tumor is very important as 20 30% of all ovarian tumors are malignant 4. Younger age at presentation and higher frequency of positive family history are two unusual features of Pakistani patient with epithelial ovarian cancer 3. Reproductive age group of women constitutes about 2/3 rd of the age group while in children it constitutes fewer than 5% 5. However ovarian tumors in infants and children are extremely rare comprising only a small proportion of all ovarian neoplasms 6. Mature cystic teratomas are recognized as one of the most common tumors in women during reproductive age group with peak incidence in the first two decades of life. The largest number of ovarian tumors comprise of the surface epithelial group, followed by ovarian germ cell tumors representing 15% 20% of all ovarian tumors out of P J M H S Vol. 9, NO. 4, OCT DEC 2015 1139

Morphological Patterns of Ovarian Neoplasms in Different Age Groups which the malignant germ cell tumors represent 5% of ovarian tumors 7. The most recent surveillance, epidemiology and results calculations of lifetime risk for ovarian cancer are that 1 in 55 women will develop ovarian cancer over their lifetime 8. Our study is based on morphological review of ovarian tumors in various age groups. The objective of the study was to study the frequency and morphological patterns of various ovarian tumors in different age groups in a tertiary care hospital. MATERIAL AND METHODS A retrospective and prospective study was conducted at the department of Pathology, BMSI, JPMC to determine the morphological patterns of all ovarian tumors received at our department over a period of five years i.e. from January 2008 to December 2012. During this period a total of 353 cases of ovarian tumors were received. All specimens were formalin fixed, routinely processed for paraffin embedding, sectioned and finally stained with haematoxylin and eosin using standard procedures. Special stains were used where necessary. RESULTS During the five years study period, a total of 1088 cases of ovarian specimens were received and documented out of which the major bulk of ovaries removed that is 447(41.8%) were unremarkable, 189(17.3%) were haemorrhagic luteal cysts and 99out of total of 1088(9%) cases were follicular cysts. The remaining 353 cases of neoplastic ovarian lesions were taken into consideration for evaluation in our study. Of the 353 ovarian tumors, 79% were benign and 63(17.8%) were malignant. Surface epithelial tumors were most common i.e., 279 out 353(79%) followed by germ cell tumors which were 59 out of 353 (16.1%) (Table 1) Benign surface epithelial tumors comprised 211/353 (59.7%) whereas their malignant counterpart formed 57/353 (16.1%) (Table 2). Most benign surface epithelial tumors were serous cyst adenomas i.e., 134/353 (37.9%) followed by mucinous cyst adenomas i.e., 76/353(21.52%). Only 1(28%) case of transitional Brenner tumor was seen in entire five years. Whereas amongst the malignant epithelial tumor 32/353 cases (9.06%) of serous cystadenocarcinomas, 21/353 (5.9%) cases of mucinous cystadenocarcinomas, 2/353 (.56%) cases of endometroid carcinoma and 2/353 (.56%) cases of malignant clear cell tumor were seen. Borderline surface epithelial tumors comprised only 11/353 (3.11%) out of which 5/353 (1.41%) were serous and 6/353 (1.61%) were mucinous in nature. Germ cell tumors constituted 16.7% (59/353) of all ovarian tumors. Most germ cell tumors were benign and composed of Mature cystic teratomas with a percentage of 14.1% (50/353) whereas the immature teratomas were relatively fewer that is 3/353 (.84%) followed by undifferentiated carcinoma that was 2/353 (.56%) Out of all ovarian neoplasms, serous surface epithelial tumors were the most commonly occurring tumor followed by mature cystic teratomas. However amongst the malignant tumors, serous cystadenocarcinomas accounted for most occurring tumor that is 32/353 (9.06%) During the course of our study, we also encountered a rare and interesting case of a collision tumor in which mucinous cystadenocarcinoma occurred in mature cystic teratoma in the ovary of a 31 years old unmarried girl. Amongst the sex cord stromal tumors the frequency of benign tumors was more than the malignant ones which in turn were rare with an occurrence of one case out of 353(.28%) in five years. The age distribution of ovarian tumors observed was that 224/353 (63.4%) tumors were found upto age 40. Out of these most were benign ovarian tumors. Malignant tumors were less common below 40 years of age. Of all malignant tumors 14% (50/353) were seen above 40 years of age whereas this figure was 9.6% (34/353) upto 40 years of age. Above 30 years, 316 ovarian tumors were found. Out of these 69.4% (245/353) were surface epithelial tumors and were most common tumors occurring above 30 years of age. Upto 30 years, 39.0% (138/353) tumors were found out of these only 28.8% (102/353) were surface epithelial tumors. In the first three decades, benign germ cell tumors were most common preceded only by surface epithelial tumors (Table 3A). Benign serous tumors were found in the 15 95 years of lifespan. Serons cystadenocarcinomas were not seen upto 20 years of age. Most serous cystadenocarcinomas were above 40 years of age. Borderline ovarian neoplasms accounted for only 3.11% of all ovarian tumors and comprised mainly of serous and mucinous surface epithelial tumors & were mostly seen in 3 rd 5 th decade of life. Benign mucinous tumors were found from 15 70 years of life but most were in the 3 rd 5 th decade. Like their serous counterpart, majority of mucinous cystadenocarcinoma were also not seen upto 30 1140 P J M H S Vol. 9, NO. 4, OCT DEC 2015

Rafia Bilquees Siddiqui, Bhawani Shankar 2, M. Irfan Khan years of age. 52.3% of mucinous tumors were present above age 40 years (Table 3B). Germ cell tumors were seen in all age groups, however, most frequent occurrence was between 21 50 years of age group that is 3 rd 4 th decade of life. Sex cord stromal tumors comprised only 1.7% of all ovarian tumors. They were not seen below 20 years of age. Table 1 Surface Epithelial Tumors Benign Borderline Malignant Serons 134 5 32 Mucinons 76 6 21 Brenner Tumor 1 - - Endometroid - - 2 Clear Cell Carcinoma - - 2 Total 211(59.7%) 11(3.11%) 57(16.14%) Table 1A: Relative frequencies of benign and malignant ovarian tumors (n=353) Cases of tumor Benign (%) Borderline (%) Malignant (%) Total (%) Surface epithelial tumors 211 (59.7%) 11 (3.1%) 57 (16.1%) 279 (79.0%) Germ Cell tumors 54 (15.2%) - 05 (1.4%) 59 (16.7%) Sex cord stromal tumors 14 (3.9%) - 01 (0.28%) 15 (4.2%) Total 279 (79%) 11 (3.1%) 63 (17.8) 353 (100%) Table 2: Age wise distribution of different benign and malignant tumors Ages (Years) SE tumors GC tumors SCS tumors Total Upto 20 25 09 01 35 21-30 77 24 04 105 31-40 70 11 05 86 41-50 47 07 06 60 51-60 39 06 01 46 > 60 16 02 03 21 Total: 274 59 20 353 SE: Surface epithelial tumors GCT: Germ Cell tumors SCS: Sex cord stromal tumors Table 3A: Frequency of various types of benign ovarian tumors according to age groups Diagnosis Age in years Upto 20 21-30 31-40 41-50 51-60 >60 Total Mature Cystic teratoma 4 19 12 7 6 2 50 Serous cystadenoma 9 40 37 21 17 8 132 Mucinous cystadenoma 9 24 16 18 11 4 82 Thecomas 0 2 0 3 0 0 5 Germ Cell tumors 0 0 1 3 1 0 5 Brenner tumor 0 0 0 0 0 1 1 Fibromas 0 1 2 0 0 1 4 Total: 22 86 68 52 35 16 279 Table 3B: Frequency of various types of malignant tumors according to age groups Diagnosis Age in years Upto 20 21-30 31-40 41-50 51-60 >60 Total Serous Cystic 0 3 6 8 10 5 32 adenocarcinoma Mucinouscyst 1 4 5 16 3 0 19 adenocarcinoma Immature teratoma 2 1 0 0 0 0 3 Dysgerminoma 3 1 0 0 0 0 4 Undifferentiated round to 1 1 0 0 0 0 2 oval tumor Malignant clear cell tumor 1 1 0 0 0 0 2 Lipid cell tumor 0 1 0 0 0 0 1 Total 22 86 68 52 35 16 279 P J M H S Vol. 9, NO. 4, OCT DEC 2015 1141

ORIGINAL ARTICLE DISCUSSION Ovarian cancer is among the ten most commonly occurring cancers 2. Our study reports an analysis of 353 ovarian tumors of which the major bulk was of surface epithelial tumors which have been further sub classified and analyzed. In this study 79% of the tumors are benign and 17.8% are of malignant nature whereas only 3.11% fall in the borderline category. In our study surface epithelial tumors comprised 79% of all ovarian tumors. This is in contrast to studies carried out with similar criteria in neighboring countries like Nepal where surface epithelial tumors were only 52.2% of all ovarian neoplasms 5. Nevertheless, a study carried in Iran shows the incidence of surface epithelial tumors as 67.1% 9. Our study shows that 48.4% (171/353) of ovarian neoplasms are of serous variety, of which 37.9% (134/353) are benign and 9.0% (32/353) are malignant and only 1.4% are borderline serous tumors. Mucinous tumors here comprised 29.1% (103/353) of all ovarian tumors as well, as this figure is 30% of all ovarian tumors in other studies 3,4. Serous tumors were found to be more common than mucinous tumors. Similar results have been compiled by other hospital based studies in neighbouring countries where serous tumors outnumbered the mucinous variety 8, 13. In our study, the serous cystadenoma surpassed as the commonest benign tumor and serous cystadenocarcinoma as the commonest malignant tumor. This is in contrast to a study conducted by R. Jha and Karki, 2008 in Nepal where mature cystic teratoma is by far the commonest benign tumor. Regarding the borderline ovarian tumors, most were of surface epithelial origin and accounted for 3.1% of all ovarian tumors. Another study done by Sohail et al, 2012 showed the occurrence of borderline ovarian tumors to be 1.6% of all ovarian tumors and the mean age of patients was more than 40 years old 13. It was also noted by them that patients with borderline ovarian tumors were younger than those with massive carcinoma and the risk decreases with increasing parity 13. A study conducted in India is in consistence with our results where the germ cell tumors comprised the second most common group of ovarian neoplasms that is 24.3% of all ovarian tumors owing to the frequent occurrence of mature cystic teratoma whereas this figure was 14.1% (50/353) for mature cystic teratoma in our study. A study based on the childhood tumors accounts for more than 80% occurrence of germ cell neoplasms amongst all ovarian cancers 7. In our study 94.3% (50/53) of germ cell tumors were mature cystic teratomas and only 5.6% (3/53) were immature cystic teratoma. Similar figures have been found in studies conducted in other countries. In a study conducted in France, 15% 20% of all ovarian tumors are of germ cell variety, 95% are mature cystic teratomas and only 5% immature cystic teratomas 7, also in consistence with our study. Sex cord stromal tumors account for 4.2% of all ovarian tumors and is in consistence with the data submitted in the west 6 whereas this data was 3% in a study in Nepal 9 and 6.8% in a study from India 10. The incidence of gynecologic malignancies is highly dependent on age. Similar to our study, other studies also show that most ovarian tumors occurred in women of reproductive age groups. Peak incidence for ovarian tumors is 21 50 years. The variation in the occurrence of benign tumors in all the age groups and malignant tumors in the elderly is also conspicuous and in consistence with other studies. The age of the patients in our study varied from 9-95 years old. Majority of benign serous tumors occurred in the 4 6 th decade of life but occurrence in patients younger than 20 and older than 70 has also been noted. Mucinous cystadenomas may occur at any age but mostly occurred between 21 60 years of age groups. The malignant counterpart had a mean age of 42 yrs. Among the children and adolescents, the malignant germ cell tumors are the most prevalent. In a study conducted in France, the germ cells tumors of ovary represent 15 20% of all ovarian tumors. Mature cystic teratomas account for half of ovarian neoplasms that appear in first two decades of life and mostly occur in the reproductive age group. Malignant transformation of mature cystic teratoma is an uncommon complication occurring in approx. 1 3% of all mature teratomas 11. We encountered just one such case in our five year study span, where mucinous cystadenocarcinoma occurred in a mature cystic teratoma. Adenocarcinoma arising in a mature cystic teratoma is extremely rare. Definite diagnosis is most often rendered postoperatively. The malignant transformation is rare and just 6.8% and prognosis is very poor 12. Conclusively we can say that benign tumors are more common than malignant ones for all age groups. Surface epithelial tumors comprise the most frequently occurring and the benign surface epithelial tumor being the most common, whereas the malignant serous epithelial tumors as the most frequent malignant ovarian tumor which occurs most frequently in the age group 21 50 years. Germ cell tumors are most frequent in the adolescents. P J M H S Vol. 9, NO. 4, OCT DEC 2015 1142

Rafia Bilquees Siddiqui, Bhawani Shankar 2, M. Irfan Khan REFERENCES 1. Kayastha S. Study of ovarian tumors in Nepal Medical College Teaching Hospital. Nepal med Coll J 2009; 11:200-202. 2. Sarwar CMS, Siddiqui N, Khokar RA, Babar F. Epithelial ovarian cancer at a cancer hospital in a developing country. Asia Pac J Can Prevent 2006; 7:595-598. 3. Malik IA. A prospective study of clinicopatholgoical features of epithelial ovarian cancer in Pakistan. National Cancer Institute, Karachi. 4. Wasim T, Siddiq S, Memon A. Comparison of clinical presentation of benign and malignant ovarian tumors. J Pak Med Assoc; 2010 5. Jha R, Karki S. Histological pattern of ovarian tumors and their age distribution. Nepal med Coll J 2008; 10: 81-85. 6. Vecchia CL, Morris HB, Draper GJ. Malignant ovarian tumors in childhood in Britain. Br J Cancer 1983; 48: 363-374. 7. Ray-Coquard I. Ovarian germ cell malignant tumors. Orphanet Encyclopedia,2004. 8. Yasmin S, Yasmin A, Asif M. Clinicohistological pattern of ovarian tumors in Peshawar region. J Ayub Med Coll 2008; 20: 9. Gilani MM, Bchnamfar F, Zamani F, Zami N. Frequency of different types of ovarian cancers in Valie-Asr Hospital. Pak J Biol Sci 2007;10: 3026-3028. 10. Griffiths D, Wars J, Look K, Sutton G. Malignant degeneration of mature cystic teratoma five decades after discovery.gynaecol Oncol 1995; 59:427-429. 11. Park J, Whang SO, Song ES, Choi SJ, Lec WJ. An ovarian mucinous cystadenocarcinoma arising from mature cystic teratoma with para aortic lymph node metastasis. J Gynaecol Oncol 2008;19:275-278. 12. Bhattacharya MM, Shinde SD, Purandare VN. A clinicopathologic analysis of 270 ovarian tumors. J Postgrad Med 1980;26:103-107. 13. Sohail I, Hayat Z, Saeed S. A comparative analysis of frequency and patterns of ovarian tumors at a tertiary care hospital between two different study periods(2002-2009). J Postgrad Med Inst 2012;26:196-200. P J M H S Vol. 9, NO. 4, OCT DEC 2015 1143